Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Verapamil Versus Metoprolol for Rate Control in Hemodynamically Stable Atrial Fibrillation With Rapid Ventricular Response

NCT07706075 is registered in ClinicalTrials.gov with Muhammad Ali Javed as lead sponsor.

NCT NCT07706075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07706075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Verapamil Versus Metoprolol for Rate Control in Hemodynamically Stable Atrial Fibrillation With Rapid Ventricular Response
Lead sponsor
Muhammad Ali Javed
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 1, 2027
Completion date
August 1, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation (af), atrial fibrillation with rapid ventricular response